BioCryst Pharmaceuticals
BCRX
#5073
Rank
HK$12.43 B
Marketcap
HK$59.09
Share price
-3.07%
Change (1 day)
-3.15%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Cash on Hand

Cash on Hand as of September 2025 : HK$1.65 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has HK$1.65 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioCryst Pharmaceuticals - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$2.49 B-18.01%
2023-12-31HK$3.03 B-8.36%
2022-12-31HK$3.31 B-16.24%
2021-12-31HK$3.95 B69.98%
2020-12-31HK$2.32 B119.47%
2019-12-31HK$1.06 B29.69%
2018-12-31HK$0.81 B-8.47%
2017-12-31HK$0.89 B110.9%
2016-12-31HK$0.42 B6.04%
2015-12-31HK$0.39 B-29.2%
2014-12-31HK$0.56 B91.28%
2013-12-31HK$0.29 B6.94%
2012-12-31HK$0.27 B-14.84%
2011-12-31HK$0.32 B-22.82%
2010-12-31HK$0.41 B-21.49%
2009-12-31HK$0.53 B12.46%
2008-12-31HK$0.47 B20.28%
2007-12-31HK$0.39 B35.69%
2006-12-31HK$0.29 B-25.24%
2005-12-31HK$0.38 B116.39%
2004-12-31HK$0.18 B16%
2003-12-31HK$0.15 B-18.58%
2002-12-31HK$0.19 B-23.56%
2001-12-31HK$0.24 B29.81%
2000-12-31HK$0.19 B7.07%
1999-12-31HK$0.17 B88.32%
1998-12-31HK$95.29 M223.6%
1997-12-31HK$29.44 M5.76%
1996-12-31HK$27.84 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Repligen
RGEN
HK$5.82 B 251.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$6.62 B 299.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$12.13 M-99.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$5.93 B 258.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$57.20 B 3,352.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$4.54 B 173.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$34.59 B 1,987.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
HK$1.91 B 15.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
HK$13.95 M-99.16%๐Ÿ‡บ๐Ÿ‡ธ USA